News Daily News USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women Caitlin E. Cox December 12, 2017
News Conference News AHA 2017 Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma Todd Neale November 15, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Daily News DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis Michael O'Riordan October 19, 2017
News Daily News Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early Todd Neale October 09, 2017
News Daily News Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis Caitlin E. Cox September 19, 2017
News Daily News Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke Yael L. Maxwell September 18, 2017
News Daily News Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis Yael L. Maxwell August 14, 2017
News Daily News Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High Todd Neale July 12, 2017
News Daily News Avoiding Autopsy: CT and Coronary Angiography Can Play a Role Postmortem Todd Neale June 06, 2017
News Daily News Anticoagulation in Pregnant Women With Mechanical Heart Valves: A Balancing Act Caitlin E. Cox May 31, 2017
News Daily News Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast Yael L. Maxwell May 10, 2017
News Conference News ACC 2017 Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients L.A. McKeown March 21, 2017
Presentation ACC 2017 EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Presenter: Jeff Weitz March 20, 2017
News Conference News ACC 2017 Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE L.A. McKeown March 18, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Testing Testosterone: Two Studies Show Nothing to Promote Its Use Among Cardiovascular Patients Yael L. Maxwell February 24, 2017